GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


MEDICINES BENEFIT-RISK ASSESSMENT

INTRODUCTION TO QUALITATIVE BENEFIT-RISK FRAMEWORKS

This course aims to give you an introduction into the principles and methods of comparative benefit-risk (BR) assessment and its role in the process of decision making.

It mainly focuses on the different qualitative frameworks and basic quantitative methods for BR assessment, including their potentials and limitations.

60 minutes
English
DRUG LIFE CYCLE AS A TOOL IN DRUG POLICY ANALYSIS

This course intends you to develop a:

  • better understanding of the dynamics of drug development and use between bench, bedside and public spheres.
  • better understanding of the changing scientific, political and social economies of drug markets social economies of drug markets.
  • better understanding of drug life cycle management as a strategic policy instrument for drug companies and regulators.
60 minutes
English
INTRODUCTION TO QUANTITATIVE BENEFIT-RISK ANALYSES METHODS

This course aims to give you an inclusive overview of the concept and scope benefit-risk evaluations of medicines, to inform you on the sources and integration of data for benefit-risk and at least to clarify the criteria for benefit-risk assessment model.

60 minutes
English
MAIN CHALLENGES OF HEALTH ECONOMICS AND OUTCOMES RESEARCH

This course is designed to give you the crucial elements and scope of the Health Technology Assessment (HTA) and of the current health care system.

The examples taken in this course are volontary focused on well known drug that we can study with hindsight rather that new drugs that may be more opened to discussions.

240 minutes
English

COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners